These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37987804)

  • 41. Green-Sensitive, Long-Lived, Step-Functional Anion Channelrhodopsin-2 Variant as a High-Potential Neural Silencing Tool.
    Kojima K; Miyoshi N; Shibukawa A; Chowdhury S; Tsujimura M; Noji T; Ishikita H; Yamanaka A; Sudo Y
    J Phys Chem Lett; 2020 Aug; 11(15):6214-6218. PubMed ID: 32697087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins.
    Nussinovitch U; Shinnawi R; Gepstein L
    Cardiovasc Res; 2014 Apr; 102(1):176-87. PubMed ID: 24518144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-invasive manipulation of Drosophila behavior by two-photon excited red-activatable channelrhodopsin.
    Hsiao PY; Tsai CL; Chen MC; Lin YY; Yang SD; Chiang AS
    Biomed Opt Express; 2015 Nov; 6(11):4344-52. PubMed ID: 26601000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating the feasibility of channelrhodopsin variants for nanoscale optogenetics.
    Stahlberg MA; Ramakrishnan C; Willig KI; Boyden ES; Deisseroth K; Dean C
    Neurophotonics; 2019 Jan; 6(1):015007. PubMed ID: 30854405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Broad spectral excitation of opsin for enhanced stimulation of cells.
    Satpathy S; Batabyal S; Dhakal KR; Lin J; Kim YT; Mohanty SK
    Opt Lett; 2015 Jun; 40(11):2465-8. PubMed ID: 26030533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Channelrhodopsins for Cell-Type Specific Illumination of Cardiac Electrophysiology.
    Fernández MC; Kopton RA; Simon-Chica A; Madl J; Hilgendorf I; Zgierski-Johnston CM; Schneider-Warme F
    Methods Mol Biol; 2021; 2191():287-307. PubMed ID: 32865751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2.
    Reinbothe TM; Safi F; Axelsson AS; Mollet IG; Rosengren AH
    Islets; 2014; 6(1):e28095. PubMed ID: 25483880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-Optical Miniaturized Co-culture Assay of Voltage-Gated Ca
    Agus V; Janovjak H
    Methods Mol Biol; 2020; 2173():247-260. PubMed ID: 32651923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation and Crystallization of the D156C Form of Optogenetic ChR2.
    Zhang L; Wang K; Ning S; Pedersen PA; Duelli AS; Gourdon PE
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optogenetic activation of spinal microglia triggers chronic pain in mice.
    Yi MH; Liu YU; Umpierre AD; Chen T; Ying Y; Zheng J; Dheer A; Bosco DB; Dong H; Wu LJ
    PLoS Biol; 2021 Mar; 19(3):e3001154. PubMed ID: 33739978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maintenance of optogenetic channel rhodopsin (ChR2) function in aging mice: Implications for pharmacological studies of inhibitory synaptic transmission, quantal content, and calcium homeostasis.
    DuBois DW; Murchison DA; Mahnke AH; Bang E; Winzer-Serhan U; Griffith WH; Souza KA
    Neuropharmacology; 2023 Nov; 238():109651. PubMed ID: 37414332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hybrid upconversion nanomaterials for optogenetic neuronal control.
    Shah S; Liu JJ; Pasquale N; Lai J; McGowan H; Pang ZP; Lee KB
    Nanoscale; 2015 Oct; 7(40):16571-7. PubMed ID: 26415758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulating cardiac physiology in engineered heart tissue with the bidirectional optogenetic tool BiPOLES.
    Schwarzová B; Stüdemann T; Sönmez M; Rössinger J; Pan B; Eschenhagen T; Stenzig J; Wiegert JS; Christ T; Weinberger F
    Pflugers Arch; 2023 Dec; 475(12):1463-1477. PubMed ID: 37863976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unraveling ChR2-driven stochastic Ca2+ dynamics in astrocytes: A call for new interventional paradigms.
    Moshkforoush A; Balachandar L; Moncion C; Montejo KA; Riera J
    PLoS Comput Biol; 2021 Feb; 17(2):e1008648. PubMed ID: 33566841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
    Nyns ECA; Kip A; Bart CI; Plomp JJ; Zeppenfeld K; Schalij MJ; de Vries AAF; Pijnappels DA
    Eur Heart J; 2017 Jul; 38(27):2132-2136. PubMed ID: 28011703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ChR2 mutants at L132 and T159 with improved operational light sensitivity for vision restoration.
    Pan ZH; Ganjawala TH; Lu Q; Ivanova E; Zhang Z
    PLoS One; 2014; 9(6):e98924. PubMed ID: 24901492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Visual Responses of Photoreceptor-Degenerated Rats Expressing Two Different Types of Channelrhodopsin Genes.
    Sato M; Sugano E; Tabata K; Sannohe K; Watanabe Y; Ozaki T; Tamai M; Tomita H
    Sci Rep; 2017 Jan; 7():41210. PubMed ID: 28112267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extending the Time Domain of Neuronal Silencing with Cryptophyte Anion Channelrhodopsins.
    Govorunova EG; Sineshchekov OA; Hemmati R; Janz R; Morelle O; Melkonian M; Wong GK; Spudich JL
    eNeuro; 2018; 5(3):. PubMed ID: 30027111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Machine learning-guided channelrhodopsin engineering enables minimally invasive optogenetics.
    Bedbrook CN; Yang KK; Robinson JE; Mackey ED; Gradinaru V; Arnold FH
    Nat Methods; 2019 Nov; 16(11):1176-1184. PubMed ID: 31611694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.